These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38503757)

  • 1. Design of hepadnavirus core protein-based chimeric virus-like particles carrying epitopes from respiratory syncytial virus.
    Shao S; Zhang XF; Hou JW; Yang SS; Han ZB; Wu HL; Tang F; Li XY; Lei ZH; Zhao ZX; Li SX; Liu ZM; Shan P; Jin YQ; Su JG; Liang Y; Zhang J; Li QM
    NPJ Vaccines; 2024 Mar; 9(1):62. PubMed ID: 38503757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction and immunological evaluation of hepatitis B virus core virus-like particles containing multiple antigenic peptides of respiratory syncytial virus.
    Lei L; Qin H; Luo J; Tan Y; Yang J; Pan Z
    Virus Res; 2021 Jun; 298():198410. PubMed ID: 33819519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.
    Lee YN; Hwang HS; Kim MC; Lee YT; Kim YJ; Lee FE; Kang SM
    Nanomedicine; 2016 Apr; 12(3):759-770. PubMed ID: 26656630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative Virus-Like Particle-Associated Prefusion F Proteins as Maternal Vaccines for Respiratory Syncytial Virus.
    Blanco JCG; Fernando LR; Zhang W; Kamali A; Boukhvalova MS; McGinnes-Cullen L; Morrison TG
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31511382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric virus-like particles containing a conserved region of the G protein in combination with a single peptide of the M2 protein confer protection against respiratory syncytial virus infection.
    Qiao L; Zhang Y; Chai F; Tan Y; Huo C; Pan Z
    Antiviral Res; 2016 Jul; 131():131-40. PubMed ID: 27154395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Respiratory Syncytial Virus (RSV) G Protein Enhances the Immune Responses to the RSV F Protein in an Enveloped Virus-Like Particle Vaccine Candidate.
    McGinnes Cullen L; Luo B; Wen Z; Zhang L; Durr E; Morrison TG
    J Virol; 2023 Jan; 97(1):e0190022. PubMed ID: 36602367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single intranasal administration of virus-like particle vaccine induces an efficient protection for mice against human respiratory syncytial virus.
    Jiao YY; Fu YH; Yan YF; Hua Y; Ma Y; Zhang XJ; Song JD; Peng XL; Huang J; Hong T; He JS
    Antiviral Res; 2017 Aug; 144():57-69. PubMed ID: 28529001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a respiratory syncytial virus vaccine using human hepatitis B core-based virus-like particles to induce mucosal immunity.
    Huang JM; Wang SY; Lai MR; Tseng YK; Chi YH; Huang LM
    Vaccine; 2021 Jun; 39(24):3259-3269. PubMed ID: 33972124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Respiratory Syncytial Virus-Like Particle Vaccine Composed of the Postfusion and Prefusion Conformations of the F Glycoprotein.
    Cimica V; Boigard H; Bhatia B; Fallon JT; Alimova A; Gottlieb P; Galarza JM
    Clin Vaccine Immunol; 2016 Jun; 23(6):451-9. PubMed ID: 27030590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins.
    Lee S; Quan FS; Kwon Y; Sakamoto K; Kang SM; Compans RW; Moore ML
    Antiviral Res; 2014 Nov; 111():129-35. PubMed ID: 25239522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice.
    Quan FS; Kim Y; Lee S; Yi H; Kang SM; Bozja J; Moore ML; Compans RW
    J Infect Dis; 2011 Oct; 204(7):987-95. PubMed ID: 21881112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human metapneumovirus virus-like particles induce protective B and T cell responses in a mouse model.
    Cox RG; Erickson JJ; Hastings AK; Becker JC; Johnson M; Craven RE; Tollefson SJ; Boyd KL; Williams JV
    J Virol; 2014 Jun; 88(11):6368-79. PubMed ID: 24672031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Previous Respiratory Syncytial Virus Infection on Murine Immune Responses to F and G Protein-Containing Virus-Like Particles.
    McGinnes Cullen L; Schmidt MR; Morrison TG
    J Virol; 2019 May; 93(9):. PubMed ID: 30760576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pan-Pneumovirus vaccine based on immunodominant epitopes of the fusion protein.
    Huang J; Miller RJ; Mousa JJ
    Front Immunol; 2022; 13():941865. PubMed ID: 36003370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection.
    Hassebroek AM; Sooryanarain H; Heffron CL; Hawks SA; LeRoith T; Cecere TE; Stone WB; Walter D; Mahsoub HM; Wang B; Tian D; Ivester HM; Allen IC; Auguste AJ; Duggal NK; Zhang C; Meng XJ
    J Med Virol; 2023 Feb; 95(2):e28503. PubMed ID: 36655751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice.
    Luo J; Qin H; Lei L; Lou W; Li R; Pan Z
    Front Immunol; 2022; 13():1054005. PubMed ID: 36578490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two RSV Platforms for G, F, or G+F Proteins VLPs.
    Ha B; Yang JE; Chen X; Jadhao SJ; Wright ER; Anderson LJ
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32824936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baculovirus-expressed virus-like particle vaccine in combination with DNA encoding the fusion protein confers protection against respiratory syncytial virus.
    Lee JS; Kwon YM; Hwang HS; Lee YN; Ko EJ; Yoo SE; Kim MC; Kim KH; Cho MK; Lee YT; Lee YR; Quan FS; Kang SM
    Vaccine; 2014 Oct; 32(44):5866-74. PubMed ID: 25173478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.